Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib.

about

Prognostic value of tumor markers, NSE, CA125 and SCC, in operable NSCLC Patients Decreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancer.

P2860

Q37007121-DC6749F1-CB3C-4217-9317-5E0E42AA3914 Q41902053-8EEF9BB9-7FBE-47EB-ABF1-9BF8C072772D

P2860

Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib.

Item

http://www.wikidata.org/entity/Q45720480

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib.

@en

Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib.

@nl

type

Item

label

Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib.

@en

Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib.

@nl

prefLabel

Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib.

@en

Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib.

@nl

P1476

Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib.

@en

P2093

A Sui

http://www.w3.org/2001/XMLSchema#string

D Tang

http://www.w3.org/2001/XMLSchema#string

M Wang

http://www.w3.org/2001/XMLSchema#string

R Yang

http://www.w3.org/2001/XMLSchema#string

W Jiao

http://www.w3.org/2001/XMLSchema#string

Y Luo

http://www.w3.org/2001/XMLSchema#string

Y Shen

http://www.w3.org/2001/XMLSchema#string

Y Wang

http://www.w3.org/2001/XMLSchema#string

Z Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer

Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression.

FoxM1 mediated resistance to gefitinib in non-small-cell lung cancer cells

Current data on predictive markers for anti-angiogenic therapy in thoracic tumours.

mRNA transcript quantification in archival samples using multiplexed, color-coded probes.

An extensive survey of tyrosine phosphorylation revealing new sites in human mammary epithelial cells

Immune function, telomerase, and angiogenesis in patients with primary, operable nonsmall cell lung carcinoma: tumor size and lymph node status remain the most important prognostic features.

BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma.

Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells.

P2888

s12094-012-0939-3

P304

384-390

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12094-012-0939-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1051357903

http://www.w3.org/2001/XMLSchema#string

P698

23065601

http://www.w3.org/2001/XMLSchema#string

Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib.

about

P2860

P2860

Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698